NASDAQ · Drug Manufacturers - General

CTOR (CTOR) Stock

$0.75 -0.92% NASDAQ: CTOR Healthcare

Valuation

MetricValue
Price$0.75
Market Cap$70.01M
P/E Ratio-2.44
P/B Ratio1.71
P/S Ratio13.69
EPS (TTM)$-0.34
52-Week High$6.19
52-Week Low$0.49
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-55.56%
ROA-24.75%
ROCE-53.33%
Gross Margin80.07%
Operating Margin-7.76%
Net Margin-7.58%
Debt/Equity0.11
Current Ratio0.57

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$0
Operating Profit$-10.0M$-12.0M$-21.0M$-24.0M
Net Profit$-11.0M$-13.0M$-21.0M$-25.0M
EPS$-0.08$-0.19$-0.30$-0.34
Op Margin————

Balance Sheet (USD)

Metric2022202320242025
Total Assets$43.0M$48.0M$84.0M$101.0M
Total Liabilities$6.0M$22.0M$38.0M$56.0M
Cash$0$0$0$4.0M
Borrowings$0$0$4.0M$4.0M

Latest News

Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption PR Newswire · Jul 21, 2026 Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies PR Newswire · Jun 1, 2026 Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting PR Newswire · May 26, 2026 Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts? Insider Monkey · May 24, 2026 Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update PR Newswire · May 15, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$0$-1.0M$0$-5.0M
Investing Cash Flow$-67.0M$-1.0M$-5.0M$-6.0M
Financing Cash Flow$0$2.0M$1.0M$0
Net Cash Flow$0$0$0$4.0M
Free Cash Flow$0$-1.0M$0$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-21.95%
Quick Ratio0.12
Interest Coverage—
Return 1Y-56.84%
Return 3Y-93.70%
Return 5Y—

Ownership

Insiders Held77.51%
Institutions Held15.32%
Institutions Float Held68.14%
Institutional HolderSharesReport Date
Armistice Capital, LLC9,188,8552026-03-31
Bank of America Corporation3,835,1602026-03-31
Vanguard Capital Management LLC534,8242026-03-31
Geode Capital Management, LLC264,7332026-03-31
Vanguard Fiduciary Trust Co121,9102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About CTOR

CTOR is led by CEO Leonard L. Mazur, employs 285 people, headquartered in US, publicly traded since 2022.

CTOR stock trades at $0.75 with a market capitalization of $70.01M. The stock is valued at a price-to-earnings (P/E) ratio of -2.44, price-to-book of 1.71, price-to-sales of 13.69. Over the past 52 weeks the stock has ranged between $0.49 and $6.19, and currently trades 87.9% below its 52-week high.

On profitability, CTOR generates a return on equity (ROE) of -55.56%, return on capital employed of -53.33%, an operating margin of -7.76%, a net profit margin of -7.58%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides